510(k) Report

510(k) · Cleared

Recalled · Class III · 2024

Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTAT

K220451510(k) TraditionalCleared Oct 5, 2023595-day reviewClass II21 CFR 862.3650Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Randox Laboratories Limited · DJG Enzyme Immunoassay, Opiates

Cleared on Oct 5, 2023 as substantially equivalent to K091454 (Medtox Diagnostics, Inc., 2009) after a 595-day review. Its family tree reaches back 4 generations to 2002. 1 later device descends from it. It has been recalled once.

Decided
Oct 5, 2023
Review
595 days
Class
Class II
Product code
DJG
Recalls
1
Predicates
1

Its longest line of descent runs back 4 generations to K014101 (2002). 8 ancestors in all, the oldest K973547 (1998). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2009: 1 other ancestor2002: 1 other ancestor2001: 1 other ancestor1998: 1 other ancestor2026: 1 descendant clearedK014101 · Rapidone-Oxy Test · American Bio Medica Corp. · 2002K040411 · Dri Oxycodone Assay · Microgenics Corp. · 2004K060351 · Medtox Oxycodone · Medtox Diagnostics, Inc. · 2006K091454 · Profile-V Medtoxscan Drugs of Abuse Test System · Medtox Diagnostics, Inc. · 20091995200020052010201520202025
Other ancestors, by generationDescendants, by generation 2 generations back: 3 other ancestors3 generations back: 1 other ancestor 1 generation forward: 1 descendant K091454 · Profile-V Medtoxscan Drugs of Abuse Test System · Medtox Diagnostics, Inc. · 2009K060351 · Medtox Oxycodone · Medtox Diagnostics, Inc. · 2006K040411 · Dri Oxycodone Assay · Microgenics Corp. · 2004K014101 · Rapidone-Oxy Test · American Bio Medica Corp. · 20020
  1. Root · 4 generations backK014101 Rapidone-Oxy TestAmerican Bio Medica Corp. · 2002
  2. 3 generations backK040411 Dri Oxycodone AssayMicrogenics Corp. · 2004
  3. 2 generations backK060351 Medtox OxycodoneMedtox Diagnostics, Inc. · 2006
  4. 1 generation backK091454 Profile-V Medtoxscan Drugs of Abuse Test SystemMedtox Diagnostics, Inc. · 2009
  5. This deviceK220451 Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTATRandox Laboratories Limited · 2023
  6. Descendant · cites it directly · 0 of its ownK250741 Evidence MultiSTAT DOA Urine MultiPlexRandox Laboratories Limited · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K250741Evidence MultiSTAT DOA Urine MultiPlexRandox Laboratories Limited · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K014101Rapidone-Oxy TestAmerican Bio Medica Corp.2002—
−3K040411Dri Oxycodone AssayMicrogenics Corp.2004—
−2K060351Medtox OxycodoneMedtox Diagnostics, Inc.2006—
−1K091454Profile-V Medtoxscan Drugs of Abuse Test SystemMedtox Diagnostics, Inc.2009—
0 (this device)K220451Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTATRandox Laboratories Limited2023—
+1K250741Evidence MultiSTAT DOA Urine MultiPlexRandox Laboratories Limited2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200110
200210
200910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K220451, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DJG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DJG device

  1. #1 K232659 Dochek® Multi-Drug Urine Test Cup Rx, Dochek®…score 17.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K091454Profile-V Medtoxscan Drugs of Abuse Test System
Summary page 5
…4. Predicate Device Proprietary Names and 510(k) Numbers The predicate device for the Evidence MultiSTAT System is the MEDTOXScan® Reader (k091454) and is detailed in table 2. Table 2: Similarities and Differences to Predicate Device Candida…
Medtox Diagnostics, Inc.2009—

Also cleared against K091454: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K250741Evidence MultiSTAT DOA Urine MultiPlexRandox Laboratories Limited20260

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 5, 2024Class IIIZ-1786-2024Device DesignFoam gasket on the Evidence MultiSTAT chip heater assembly may not perform as expected. Foam that is not functioning as expected may cause light to leak into the Charged Coupled Device (CCD) Camera during imaging. This will affect the…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 4 companies; a new generation was cleared every 3.2 years on median.
  • 1 of the 8 ancestors has a recall of any class.
  • Of its descendants, K250741 (Randox Laboratories Limited, 2026) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K091454.

How does its category compare?

All DJG devices

DJG Enzyme Immunoassay, Opiates: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · DJG

3in 2025

2007: 22008: 22009: 22010: 62011: 62012: 52013: 52014: 92015: 122016: 22017: 42018: 52019: 32020: 52021: 32022: 22023: 102024: 52025: 32026 (partial year): 3
2007high 12 (2015) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DJG

31in 2025

2010: 187 days median2011: 233 days median2012: 95 days median2013: 60 days median2014: 62 days median2015: 141 days median2017: 101 days median2018: 134 days median2019: 235 days median2020: 30 days median2021: 422 days median2023: 140 days median2024: 150 days median2025: 31 days median2026 (partial year): 157 days median
2007high 422 (2021) · low 30 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DJG

2in 2025

2011: 12019: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DJG

1in 2025

2011: 42012: 12013: 42015: 32016: 22017: 12018: 12021: 22022: 12024: 32025: 1
2007high 4 (2011) · low 0 (2007)2025

MAUDE reports naming product code DJG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
20092—00
2010618700
2011623314
201259501
201356004
201496200
20151214103
20162—02
2017410101
2018513401
2019323510
202053000
2021342202
20222—01
20231014000
2024515003
202533121
202631570—

What is it indicated for?

The Evidence MultiSTAT DOA Urine MultiPlex is intended for use with the Evidence MultiSTAT. The Evidence MultiSTAT is an analyzer intended for the qualitative determination of parent drug molecule and metabolites of drugs in human urine at the associated cutoffs. The Evidence MultiSTAT DOA Urine MultiPlex detects the following drugs at the following cut-offs: Analyte Analyte in Cut Off Material Cut-Off Benzodiazepines I Oxazepam 200 ng/mL Methamphetamine…

Read the full statement (155 words)

The Evidence MultiSTAT DOA Urine MultiPlex is intended for use with the Evidence MultiSTAT. The Evidence MultiSTAT is an analyzer intended for the qualitative determination of parent drug molecule and metabolites of drugs in human urine at the associated cutoffs.

The Evidence MultiSTAT DOA Urine MultiPlex detects the following drugs at the following cut-offs:

Analyte Analyte in Cut Off Material Cut-Off

Benzodiazepines I Oxazepam 200 ng/mL

Methamphetamine S-(+)-Methamphetamine 500 ng/mL

Noroxycodone Noroxycodone 100 ng/mL

Methadone (±)-Methadone 300 ng/mL

The Evidence MultiSTAT DOA Urine MultiPlex provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) and/or Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) are the preferred confirmatory methods. Other chemical confirmation methods are available. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are obtained.

For in vitro diagnostic use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K220451: Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTAT.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K220451

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026